Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium: YAG laser pretreatment of skin

Woan Ruoh Lee, Shin Chuan Shen, Rou Zi Zhuo, Kuo Cheng Wang, Jia You Fang

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

RNA interference (RNAi) is rapidly becoming an important tool that is advancing research with therapeutic aims. It is necessary to develop efficient ways of guiding small interfering RNA (siRNA) to targeted tissues to induce an RNAi effect. Herein, we report on an active method for delivering macromolecular siRNA and its plasmid vector into the skin, using erbium:YAG (Er:YAG) laser pretreatment. The amount of siRNA transported through nude mouse skin was determined with an in vitro Franz diffusion assembly. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo uptake of siRNA and the vector by the skin. The stratum corneum was partially ablated with the low-fluence laser. The results of in vitro experiments indicated a significant improvement in siRNA permeation with laser exposure, which showed a 2.4- to 10.2-fold increase compared with the nontreated group depending on the fluence used (1.2-1.7J/cm2). A photomechanical wave generated by filtering the laser irradiation was sufficient to enhance siRNA permeation by 5-fold. CLSM revealed intense green fluorescence from naked siRNA within the epidermis and upper dermis after laser pretreatment, producing a 3.5-fold enhancement compared with the control. The green signal intensity in 1.7J/cm2-treated skin was 4.2-fold higher than that in intact skin after the in vivo topical application of the siRNA expression vector. The increased signal was mainly in the dermis. This noninvasive, precisely controlled technique for siRNA therapy provides an efficient way to deliver siRNA and its vector into the skin.

Original languageEnglish
Pages (from-to)580-588
Number of pages9
JournalHuman Gene Therapy
Volume20
Issue number6
DOIs
Publication statusPublished - Jun 1 2009

Fingerprint

Solid-State Lasers
Small Interfering RNA
Skin
Lasers
Dermis
RNA Interference
Confocal Microscopy
Therapeutic Human Experimentation
Nude Mice
Epidermis
Cornea
Plasmids
Fluorescence

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium : YAG laser pretreatment of skin. / Lee, Woan Ruoh; Shen, Shin Chuan; Zhuo, Rou Zi; Wang, Kuo Cheng; Fang, Jia You.

In: Human Gene Therapy, Vol. 20, No. 6, 01.06.2009, p. 580-588.

Research output: Contribution to journalArticle

@article{8dab4a5cc5d04eeabdad1a5c9be66f6e,
title = "Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium: YAG laser pretreatment of skin",
abstract = "RNA interference (RNAi) is rapidly becoming an important tool that is advancing research with therapeutic aims. It is necessary to develop efficient ways of guiding small interfering RNA (siRNA) to targeted tissues to induce an RNAi effect. Herein, we report on an active method for delivering macromolecular siRNA and its plasmid vector into the skin, using erbium:YAG (Er:YAG) laser pretreatment. The amount of siRNA transported through nude mouse skin was determined with an in vitro Franz diffusion assembly. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo uptake of siRNA and the vector by the skin. The stratum corneum was partially ablated with the low-fluence laser. The results of in vitro experiments indicated a significant improvement in siRNA permeation with laser exposure, which showed a 2.4- to 10.2-fold increase compared with the nontreated group depending on the fluence used (1.2-1.7J/cm2). A photomechanical wave generated by filtering the laser irradiation was sufficient to enhance siRNA permeation by 5-fold. CLSM revealed intense green fluorescence from naked siRNA within the epidermis and upper dermis after laser pretreatment, producing a 3.5-fold enhancement compared with the control. The green signal intensity in 1.7J/cm2-treated skin was 4.2-fold higher than that in intact skin after the in vivo topical application of the siRNA expression vector. The increased signal was mainly in the dermis. This noninvasive, precisely controlled technique for siRNA therapy provides an efficient way to deliver siRNA and its vector into the skin.",
author = "Lee, {Woan Ruoh} and Shen, {Shin Chuan} and Zhuo, {Rou Zi} and Wang, {Kuo Cheng} and Fang, {Jia You}",
year = "2009",
month = "6",
day = "1",
doi = "10.1089/hum.2008.156",
language = "English",
volume = "20",
pages = "580--588",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium

T2 - YAG laser pretreatment of skin

AU - Lee, Woan Ruoh

AU - Shen, Shin Chuan

AU - Zhuo, Rou Zi

AU - Wang, Kuo Cheng

AU - Fang, Jia You

PY - 2009/6/1

Y1 - 2009/6/1

N2 - RNA interference (RNAi) is rapidly becoming an important tool that is advancing research with therapeutic aims. It is necessary to develop efficient ways of guiding small interfering RNA (siRNA) to targeted tissues to induce an RNAi effect. Herein, we report on an active method for delivering macromolecular siRNA and its plasmid vector into the skin, using erbium:YAG (Er:YAG) laser pretreatment. The amount of siRNA transported through nude mouse skin was determined with an in vitro Franz diffusion assembly. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo uptake of siRNA and the vector by the skin. The stratum corneum was partially ablated with the low-fluence laser. The results of in vitro experiments indicated a significant improvement in siRNA permeation with laser exposure, which showed a 2.4- to 10.2-fold increase compared with the nontreated group depending on the fluence used (1.2-1.7J/cm2). A photomechanical wave generated by filtering the laser irradiation was sufficient to enhance siRNA permeation by 5-fold. CLSM revealed intense green fluorescence from naked siRNA within the epidermis and upper dermis after laser pretreatment, producing a 3.5-fold enhancement compared with the control. The green signal intensity in 1.7J/cm2-treated skin was 4.2-fold higher than that in intact skin after the in vivo topical application of the siRNA expression vector. The increased signal was mainly in the dermis. This noninvasive, precisely controlled technique for siRNA therapy provides an efficient way to deliver siRNA and its vector into the skin.

AB - RNA interference (RNAi) is rapidly becoming an important tool that is advancing research with therapeutic aims. It is necessary to develop efficient ways of guiding small interfering RNA (siRNA) to targeted tissues to induce an RNAi effect. Herein, we report on an active method for delivering macromolecular siRNA and its plasmid vector into the skin, using erbium:YAG (Er:YAG) laser pretreatment. The amount of siRNA transported through nude mouse skin was determined with an in vitro Franz diffusion assembly. Confocal laser scanning microscopy (CLSM) was used to examine the in vivo uptake of siRNA and the vector by the skin. The stratum corneum was partially ablated with the low-fluence laser. The results of in vitro experiments indicated a significant improvement in siRNA permeation with laser exposure, which showed a 2.4- to 10.2-fold increase compared with the nontreated group depending on the fluence used (1.2-1.7J/cm2). A photomechanical wave generated by filtering the laser irradiation was sufficient to enhance siRNA permeation by 5-fold. CLSM revealed intense green fluorescence from naked siRNA within the epidermis and upper dermis after laser pretreatment, producing a 3.5-fold enhancement compared with the control. The green signal intensity in 1.7J/cm2-treated skin was 4.2-fold higher than that in intact skin after the in vivo topical application of the siRNA expression vector. The increased signal was mainly in the dermis. This noninvasive, precisely controlled technique for siRNA therapy provides an efficient way to deliver siRNA and its vector into the skin.

UR - http://www.scopus.com/inward/record.url?scp=68849101222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849101222&partnerID=8YFLogxK

U2 - 10.1089/hum.2008.156

DO - 10.1089/hum.2008.156

M3 - Article

C2 - 19239381

AN - SCOPUS:68849101222

VL - 20

SP - 580

EP - 588

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 6

ER -